hapabapa The Federal Trade Commission has filed an amicus curiae brief in a case being heard in a U.S. appellate court involving an alleged scheme by Gilead Sciences ( NASDAQ: GILD ) that paid Teva Pharmaceutical Industries ( NYSE: TEVA ) to delay generic.
